The next generation of DCTs: inside the technology transforming clinical trials
Within the last decade, the way clinical trials are done has been revolutionised by technology. Pharmaceutical companies are embracing the…

Established itself as the second largest market in the world, behind only the United States, the Chinese pharmaceutical sector is…
As we enter 2022, the third year of the Covid-19 pandemic, the clinical research landscape is undergoing a transformation –…
Decentralised Clinical Trials (DCTs) are trials that use digital technologies to communicate with study participants, bring clinical research closer to patient’s…
Home to a booming clinical trials market, China presents a huge opportunity for clinical innovation. Since 2015, the country has…
Alongside a large patient population, China offers a large and growing network of hospitals qualified to conduct high-standard clinical trials…
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of…
According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion by 2024 (+8% CAGR 19-24F).…
The number of biotech-sponsored clinical trials in Australia has grown by more than +10% on average each year between 2017…
Asia-Pacific biotech specialist CRO Novotech has released a new webinar about the advantages of conducting oncology clinical trials in the…
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of…
The leading Asia-Pacific biotech specialist CRO Novotech is releasing a series of webinars about the advantages of conducting clinical trials…
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment…
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the…
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
The alliance of regional specialists can provide the best of all worlds: global coverage, regional specialisation and mid-sized CRO flexibility.…
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…